101 related articles for article (PubMed ID: 29857072)
1. Efflux transporters and tight junction expression changes in human gastrointestinal cell lines cultured in defined medium vs serum supplemented medium.
Warrier A; Gunosewoyo H; Crowe A
Life Sci; 2018 Aug; 207():138-144. PubMed ID: 29857072
[TBL] [Abstract][Full Text] [Related]
2. Conditioned medium from LS 174T goblet cells treated with oxyresveratrol strengthens tight junctions in Caco-2 cells.
Hwang D; Jo H; Hwang S; Kim JK; Kim IH; Lim YH
Biomed Pharmacother; 2017 Jan; 85():280-286. PubMed ID: 27876210
[TBL] [Abstract][Full Text] [Related]
3. Development of a model for functional studies of ABCG2 (breast cancer resistance protein) efflux employing a standard BeWo clone (B24).
Crowe A; Keelan JA
Assay Drug Dev Technol; 2012 Oct; 10(5):476-84. PubMed ID: 22681401
[TBL] [Abstract][Full Text] [Related]
4. 3D-fibroblast tissues constructed by a cell-coat technology enhance tight-junction formation of human colon epithelial cells.
Matsusaki M; Hikimoto D; Nishiguchi A; Kadowaki K; Ohura K; Imai T; Akashi M
Biochem Biophys Res Commun; 2015 Feb; 457(3):363-9. PubMed ID: 25576862
[TBL] [Abstract][Full Text] [Related]
5. Permeability characteristics of parental and clonal human intestinal Caco-2 cell lines differentiated in serum-supplemented and serum-free media.
Ranaldi G; Consalvo R; Sambuy Y; Scarino ML
Toxicol In Vitro; 2003; 17(5-6):761-7. PubMed ID: 14599474
[TBL] [Abstract][Full Text] [Related]
6. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
[TBL] [Abstract][Full Text] [Related]
7. Glutamine and arginine improve permeability and tight junction protein expression in methotrexate-treated Caco-2 cells.
Beutheu S; Ghouzali I; Galas L; Déchelotte P; Coëffier M
Clin Nutr; 2013 Oct; 32(5):863-9. PubMed ID: 23428392
[TBL] [Abstract][Full Text] [Related]
8. Modulation of transendothelial permeability and expression of ATP-binding cassette transporters in cultured brain capillary endothelial cells by astrocytic factors and cell-culture conditions.
Török M; Huwyler J; Gutmann H; Fricker G; Drewe J
Exp Brain Res; 2003 Dec; 153(3):356-65. PubMed ID: 14610630
[TBL] [Abstract][Full Text] [Related]
9. Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers?
Behrens I; Kissel T
Eur J Pharm Sci; 2003 Aug; 19(5):433-42. PubMed ID: 12907294
[TBL] [Abstract][Full Text] [Related]
10. A Triple Culture Model of the Blood-Brain Barrier Using Porcine Brain Endothelial cells, Astrocytes and Pericytes.
Thomsen LB; Burkhart A; Moos T
PLoS One; 2015; 10(8):e0134765. PubMed ID: 26241648
[TBL] [Abstract][Full Text] [Related]
11. GLP-2 enhances barrier formation and attenuates TNFα-induced changes in a Caco-2 cell model of the intestinal barrier.
Moran GW; O'Neill C; McLaughlin JT
Regul Pept; 2012 Oct; 178(1-3):95-101. PubMed ID: 22809889
[TBL] [Abstract][Full Text] [Related]
12. Membrane transport of camptothecin: facilitation by human P-glycoprotein (ABCB1) and multidrug resistance protein 2 (ABCC2).
Lalloo AK; Luo FR; Guo A; Paranjpe PV; Lee SH; Vyas V; Rubin E; Sinko PJ
BMC Med; 2004 May; 2():16. PubMed ID: 15125776
[TBL] [Abstract][Full Text] [Related]
13. Peripheral nerve pericytes originating from the blood-nerve barrier expresses tight junctional molecules and transporters as barrier-forming cells.
Shimizu F; Sano Y; Maeda T; Abe MA; Nakayama H; Takahashi R; Ueda M; Ohtsuki S; Terasaki T; Obinata M; Kanda T
J Cell Physiol; 2008 Nov; 217(2):388-99. PubMed ID: 18543246
[TBL] [Abstract][Full Text] [Related]
14. Raltegravir permeability across blood-tissue barriers and the potential role of drug efflux transporters.
Hoque MT; Kis O; De Rosa MF; Bendayan R
Antimicrob Agents Chemother; 2015 May; 59(5):2572-82. PubMed ID: 25691630
[TBL] [Abstract][Full Text] [Related]
15. Cobalt chloride compromises transepithelial barrier properties of CaCo-2 BBe human gastrointestinal epithelial cell layers.
DiGuilio KM; Valenzano MC; Rybakovsky E; Mullin JM
BMC Gastroenterol; 2018 Jan; 18(1):2. PubMed ID: 29304733
[TBL] [Abstract][Full Text] [Related]
16. Silencing the breast cancer resistance protein expression and function in caco-2 cells using lentiviral vector-based short hairpin RNA.
Zhang W; Li J; Allen SM; Weiskircher EA; Huang Y; George RA; Fong RG; Owen A; Hidalgo IJ
Drug Metab Dispos; 2009 Apr; 37(4):737-44. PubMed ID: 19131524
[TBL] [Abstract][Full Text] [Related]
17. [Influence of protamine on expression of tight junction proteins in Caco-2].
Vishnevskaia ON; Burdin DV; Gorshkov AN; Grefner NM; Markov AG
Ross Fiziol Zh Im I M Sechenova; 2013 Jan; 99(1):81-91. PubMed ID: 23659059
[TBL] [Abstract][Full Text] [Related]
18. IPEC-J2 MDR1, a Novel High-Resistance Cell Line with Functional Expression of Human P-glycoprotein (ABCB1) for Drug Screening Studies.
Saaby L; Helms HC; Brodin B
Mol Pharm; 2016 Feb; 13(2):640-52. PubMed ID: 26651362
[TBL] [Abstract][Full Text] [Related]
19. Efflux transporter mRNA expression profiles in differentiating JEG-3 human choriocarcinoma cells as a placental transport model.
Ikeda K; Yamasaki K; Homemoto M; Yamaue S; Ogawa M; Nakao E; Fukunaga Y; Nakanishi T; Utoguchi N; Myotoku M; Hirotani Y
Pharmazie; 2012 Jan; 67(1):86-90. PubMed ID: 22393837
[TBL] [Abstract][Full Text] [Related]
20. Characterization of efflux transporters involved in distribution and disposition of apixaban.
Zhang D; He K; Herbst JJ; Kolb J; Shou W; Wang L; Balimane PV; Han YH; Gan J; Frost CE; Humphreys WG
Drug Metab Dispos; 2013 Apr; 41(4):827-35. PubMed ID: 23382458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
